"Clinically predictive preclinical efficacy testing services at your disposal"


Jussi Halleen - CEO, Pharmatest Services

SEPTEMBER 17, 2018

Pharmatest attends ASBMR Annual Meeting in Montreal

Pharmatest Services attends Annual Meeting of The American Society for Bone and Mineral Research (ASBMR) that will be held in Montreal, Canada on September 28 – October 1, 2018. Pharmatest attends the event with a booth (#217) and has 4 scientific presentations.

Pharmatest Services is a contract research organization that offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. ASBMR Annual Meeting is the leading scientific event in the field of bone research globally.

This year Pharmatest attends ASBMR with the following four scientific presentations:

-        Bone metastatic growth was not inhibited by anti-PD-1 blockage in a humanized mouse model of triple-negative breast cancer – difference in responses between primary and bone metastatic tumors (collaboration with Taconic Biosciences, USA).  Poster presentation LB SAT-1164 by Tiina Kähkönen on September 29, 12:30 pm - 2:30 pm at ASBMR Discovery Hall – Hall 220 B-E.

-        Intra-Articular Monosodium Iodoacetate Induced Knee Osteoarthritis: Effects on Bone as Measured by Micro-Computed Tomography in Rats. Poster presentation SAT-0986 by Jukka Vääräniemi on September 29 from 12:30 pm – 2:30 pm at ASBMR Discovery Hall – Room 220 B-E. This poster will also be presented at ASBMR Symposium on Skeletal Contributions to Joint Degeneration and Osteoarthritis (#P-49) at room 513 of the Palais des Congres on September 27, 2018 from 8:00 am – 6:00pm.

-        Analgesic Effects of Morphine on Knee Osteoarthritis Induced by Intra-Articular Monosodium Iodoacetate in Rats. Poster presentation SUN-0995 by Jukka Morko on Sunday, September 30 from 12:30 pm – 2:30 pm at ASBMR Discovery Hall – Room 220 B-E. This poster will also be presented at ASBMR Symposium on Skeletal Contributions to Joint Degeneration and Osteoarthritis (#P-44) at room 513 of the Palais des Congres on September 27, 2018 from 8:00 am – 6:00pm.

-        The effects of castration on prostate cancer tumor growth in bone (collaboration with Bayer AG, Berlin, Germany). Poster presentation MON-0215 by Tiina Kähkönen on October 1, 12:00 pm-02:00 pm at ASBMR Discovery Hall - Exhibit Hall 220 B-E.

Pharmatest welcomes everyone to visit our posters and booth #217 in the event. If you would like to schedule a meeting with our representatives during the ASBMR meeting click here.